Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-24 @ 5:09 PM
NCT ID:
NCT06501950
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of RRMS or PPMS according to the 2017 McDonald criteria
* Current treatment with monoclonal antibodies (including Natalizumab, Ofatumumab, Ocrelizumab) according to SmPC
* EDSS ≤7.0
Exclusion Criteria:
* Patients with an acute MS relapse and/or a history of intravenous corticosteroid treatment within past six weeks.
* Any comorbidity resulting in an impairment to understand or successfully complete the study such as (but not restricted to) psychiatric comorbidities or dementia. Decision will be made at investigators discretion.
* Additional immunosuppression except of above mentioned monoclonal antibodies
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06501950
Study Brief:
Protocol Section:
NCT06501950